Brachytherapy
Volume 7, Issue 4 , Pages 320-326 , October 2008

Concepts for critical organ dosimetry in three-dimensional image-based breast brachytherapy

Received 10 April 2008 ,Revised 8 August 2008 ,Accepted 8 August 2008.

References 

  1. Polgar C, Major T, Fodor J, et al. High-dose-rate brachytherapy alone versus whole breast radiotherapy with or without tumor bed boost after breast-conserving surgery: Seven-year results of a comparative study. Int J Radiat Oncol Biol Phys. 2004;60:1173–1181
  2. Das RK, Patel R, Shah H, et al. 3D CT-based high-dose-rate breast brachytherapy implants: Treatment planning and quality assurance. Int J Radiat Oncol Biol Phys. 2004;59:1224–1228
  3. Patel RR, Das RK. Image-guided breast brachytherapy: An alternative to whole-breast radiotherapy. Lancet Oncol. 2006;7:407–415
  4. Ott OJ, Schulz-Wendtland R, Uter W, et al. Fat necrosis after conserving surgery and interstitial brachytherapy and/or external-beam irradiation in women with breast cancer. Strahlenther Onkol. 2005;181:638–644
  5. Wazer DE, Kaufman S, Cuttino L, et al. Accelerated partial breast irradiation: An analysis of variables associated with late toxicity and long-term cosmetic outcome after high-dose-rate interstitial brachytherapy. Int J Radiat Oncol Biol Phys. 2006;64:489–495
  6. Patel RR, Becker SJ, Das RK, et al. A dosimetric comparison of accelerated partial breast irradiation techniques: Multicatheter interstitial brachytherapy, three-dimensional conformal radiotherapy, and supine versus prone helical tomotherapy. Int J Radiat Oncol Biol Phys. 2007;68:935–942
  7. Polgar C, Sulyok Z, Fodor J, et al. Sole brachytherapy of the tumor bed after conservative surgery for T1 breast cancer: Five-year results of a phase I-II study and initial findings of a randomized phase III trial. J Surg Oncol. 2002;80:121–128discussion 129
  8. Das RK, Bradley KA, Nelson IA, et al. Quality assurance of treatment plans for interstitial and intracavitary high-dose-rate brachytherapy. Brachytherapy. 2006;5:56–60
  9. Kolotas C, Baltas D, Zamboglou N. CT-based interstitial HDR brachytherapy. Strahlenther Onkol. 1999;175:419–427
  10. Major T, Polgar C, Mangel L, et al. CT based conformal brachytherapy treatment planning, Magy Onkol. 2000;44:109–115
  11. Cuttino LW, Todor D, Arthur DW. CT-guided multi-catheter insertion technique for partial breast brachytherapy: Reliable target coverage and dose homogeneity. Brachytherapy. 2005;4:10–17
  12. Jansen N, Deneufbourg JM, Nickers P. Adjuvant stereotactic permanent seed breast implant: A boost series in view of partial breast irradiation. Int J Radiat Oncol Biol Phys. 2007;67:1052–1058
  13. Kestin LL, Jaffray DA, Edmundson GK, et al. Improving the dosimetric coverage of interstitial high-dose-rate breast implants. Int J Radiat Oncol Biol Phys. 2000;46:35–43
  14. Major T, Fodor J, Takacsi-Nagy Z, et al. Evaluation of HDR interstitial breast implants planned by conventional and optimized CT-based dosimetry systems with respect to dose homogeneity and conformality. Strahlenther Onkol. 2005;181:89–96
  15. Ott OJ, Potter R, Hammer J, et al. Accelerated partial breast irradiation with iridium-192 multicatheter PDR/HDR brachytherapy. Preliminary results of the German-Austrian multicenter trial. Strahlenther Onkol. 2004;180:642–649
  16. Resch A, Potter R, Van Limbergen E, et al. Long-term results (10 years) of intensive breast conserving therapy including a high-dose and large-volume interstitial brachytherapy boost (LDR/HDR) for T1/T2 breast cancer. Radiother Oncol. 2002;63:47–58
  17. Sadeghi A, Prestidge B, Lee JM, et al. Evaluation of the surface radiation dose and dose gradient in early stage breast cancer using high-dose-rate brachytherapy MammoSite applicator. Brachytherapy. 2006;5:230–234
  18. Wazer DE, Kramer B, Schmid C, et al. Factors determining outcome in patients treated with interstitial implantation as a radiation boost for breast conservation therapy. Int J Radiat Oncol Biol Phys. 1997;39:381–393
  19. Nath R, Anderson LL, Luxton G, et al. Dosimetry of interstitial brachytherapy sources: Recommendations of the AAPM Radiation Therapy Committee Task Group No. 43. American Association of Physicists in Medicine. Med Phys. 1995;22:209–234
  20. Dale RG. The application of the linear-quadratic dose-effect equation to fractionated and protracted radiotherapy. Br J Radiol. 1985;58:515–528
  21. Dale RG, Coles IP, Deehan C, et al. Calculation of integrated biological response in brachytherapy. Int J Radiat Oncol Biol Phys. 1997;38:633–642
  22. Fowler J, Mount M. Pulsed brachytherapy: The conditions for no significant loss of therapeutic ratio compared with traditional low dose rate brachytherapy. Int J Radiat Oncol Biol Phys. 1992;23:661–669
  23. Turesson I, Nyman J, Holmberg E, et al. Prognostic factors for acute and late skin reactions in radiotherapy patients. Int J Radiat Oncol Biol Phys. 1996;36:1065–1075
  24. Van Limbergen E, van der Schueren E, Van Tongelen K. Cosmetic evaluation of breast conserving treatment for mammary cancer. 1. Proposal of a quantitative scoring system. Radiother Oncol. 1989;16:159–167
  25. Georg P, Georg D, Van Limbergen E. The use of the source-skin distance measuring bridge indeed reduces skin teleangiectasia after interstitial boost in breast conserving therapy. Radiother Oncol. 2005;74:323–330
  26. Perera F, Chisela F, Stitt L, et al. TLD skin dose measurements and acute and late effects after lumpectomy and high-dose-rate brachytherapy only for early breast cancer. Int J Radiat Oncol Biol Phys. 2005;62:1283–1290
  27. Van Limbergen E, Briot E, Drijkoningen M. The source-skin distance measuring bridge: A method to avoid radiation teleangiectasia in the skin after interstitial therapy for breast cancer. Int J Radiat Oncol Biol Phys. 1990;18:1239–1244
  28. Ott OJ, Lotter M, Sauer R, et al. Accelerated partial-breast irradiation with interstitial implants: The clinical relevance of the calculation of skin doses. Strahlenther Onkol. 2007;183:426–431
  29. Pantelis E, Papagiannis P, Karaiskos P, et al. The effect of finite patient dimensions and tissue inhomogeneities on dosimetry planning of 192Ir HDR breast brachytherapy: A Monte Carlo dose verification study. Int J Radiat Oncol Biol Phys. 2005;61:1596–1602
  30. Garza R, Albuquerque K, Sethi A. Lung and cardiac tissue doses in left breast cancer patients treated with single-source breast brachytherapy compared to external beam tangent fields. Brachytherapy. 2006;5:235–238
  31. Kwa SL, Lebesque JV, Theuws JC, et al. Radiation pneumonitis as a function of mean lung dose: An analysis of pooled data of 540 patients. Int J Radiat Oncol Biol Phys. 1998;42:1–9
  32. Graham MV, Purdy JA, Emami B, et al. Clinical dose-volume histogram analysis for pneumonitis after 3D treatment for non-small cell lung cancer (NSCLC). Int J Radiat Oncol Biol Phys. 1999;45:323–329
  33. Taylor CW, Nisbet A, McGale P, et al. Cardiac exposures in breast cancer radiotherapy: 1950s-1990s. Int J Radiat Oncol Biol Phys. 2007;69:1484–1495

PII: S1538-4721(08)00606-5

doi: 10.1016/j.brachy.2008.08.002

Brachytherapy
Volume 7, Issue 4 , Pages 320-326 , October 2008

Article Tools

* Image Usage & Resolution